查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1990117

食道支架市場：按產品類型、應用和最終用戶分類的全球市場預測 - 2026-2032 年

Esophageal Stents Market by Product Type, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，食道支架市場價值將達到 1.6992 億美元，到 2026 年將成長至 1.7969 億美元，到 2032 年將達到 2.6342 億美元，複合年成長率為 6.46%。

主要市場統計數據
基準年 2025 1.6992億美元
預計年份：2026年 1.7969億美元
預測年份 2032 2.6342億美元
複合年成長率 (%) 6.46%

在器械設計創新、手術環境和相關人員決策因素方面，闡明食道支架的臨床意義和商業性背景。

食道支架已成為阻塞性和穿孔性食道疾病多學科診療路徑中的核心治療方法，根據臨床情況，彌合了安寧療護、根治性治療和臨時干預之間的差距。材料科學、輸送系統和支架設計方面的最新創新拓寬了臨床醫生的選擇範圍，並最佳化了手術流程；與此同時，不斷變化的醫保報銷模式和門診環境的改變正在重塑醫療服務的提供方式。隨著器械的不斷發展，從介入性胃腸病學家到醫院供應鏈管理人員等相關人員都面臨著臨床療效、手術效率和長期耐用性之間複雜的權衡取捨。

材料、輸送系統、監管重點和臨床環境的轉變如何共同重新定義食道支架的臨床實踐和商業模式。

食道支架領域正經歷一場變革，其驅動力來自於技術的進步、臨床實踐的不斷發展以及供應鏈的現代化。材料科學的進步加速了具有更佳徑向力控制和貼合度的自膨脹金屬支架的普及應用，而生物可分解聚合物的進步則為臨時支架提供了新的選擇，從而減少了取出支架的需要。輸送系統的微型化和透視成像的改善在許多情況下縮短了手術時間，使得更多手術能夠從住院手術室轉移到門診手術中心和專科診所。因此，臨床醫生可以提供創傷更小、恢復更快的治療方案，這正在重塑轉診模式以及與保險公司的溝通方式。

對美國對進口醫療設備組件和成品徵收關稅措施所造成的營運、臨床進入和採購影響進行全面評估。

美國2025年實施的新關稅措施引發了食道支架整個價值鏈的一系列營運和戰略應對措施，影響範圍涵蓋從原料採購到醫院採購委員會的方方面面。關稅帶來的成本壓力促使醫療設備製造商重新評估其採購管道，並探索替代材料和國內供應合約以降低風險。一些公司加快了與優選合作夥伴整合組件採購的步伐，以維持價格和前置作業時間的可預測性；而另一些公司則正在分階段進行產品重新設計，以減少對關稅敏感型原料的依賴。

細分市場對產品設計、臨床選擇標準和採購方法的影響，源自於產品、應用和最終用戶之間的詳細差異。

市場區隔洞察表明，為了最大限度地提高臨床適用性和商業性吸引力，器械策略和商業化必須根據產品設計、臨床適應症和終端用戶環境進行精細調整。從可生物分解平台到塑膠結構和自膨式金屬支架，每種產品類型都有其獨特的臨床權衡。可生物分解支架適用於臨時支撐場景，避免移除可帶來臨床效益。同時，由聚乙烯和聚氨酯組成的塑膠支架在成本、植入便利性或特定機械性能優先考慮的特定細分市場中仍然發揮作用。自膨式金屬包覆器械有鎳鈦合金和不銹鋼兩種材質，其適應性和徑向強度存在差異，這會影響瘻管閉合和惡性狹窄緩解的選擇。相反，自膨式金屬裸支架（同樣有鎳鈦合金和不銹鋼兩種材質）在組織浸潤和長期通暢性對臨床決策至關重要時仍然是重要的選擇。

美洲、歐洲、中東和非洲以及亞太地區的區域法規結構、支付方結構和供應鏈現實如何影響採用和商業化策略？

區域趨勢對食道支架的法規結構、報銷機制和臨床應用模式有顯著影響，因此，各地區的製造商和服務供應商需要採取差異化的策略。在美洲，臨床上對微創介入治療的重視以及成熟的報銷體係正在推動先進自膨式金屬支架的應用，並將支架相關的療效數據納入基於價值的合約談判中。同時，該地區的供應鏈中斷和複雜的關稅問題促使製造商與大型醫院系統加強合作，以確保供應的連續性，並使合約條款與手術量相符。

透過材料創新、數據驅動的臨床支持和影響合約取得和臨床醫生採納的策略性商業性夥伴關係實現競爭差異化。

企業格局正因產品創新、策略夥伴關係以及對供應鏈和監管要求的快速應對力而重塑。主要企業正透過投資材料科學、最佳化鎳鈦諾和不銹鋼合金的製程以實現更精細的徑向力分佈，以及推進用於臨時支架植入的可生物分解聚合物配方，來打造差異化優勢。此外，多家公司正透過提供培訓項目、數位化手術規劃工具和基於註冊的療效追蹤，拓展其價值提案，超越單純的器械供應，從而加速產品在臨床環境中的應用，並支持與支付方進行價值對話。

為製造商和醫療保健系統領導者提供切實可行的優先步驟，以加強證據產生、實現供應鏈多元化，並使商業模式與臨床要求保持一致。

行業領導者應採取多管齊下的方法，整合臨床證據的積累、供應鏈的韌性以及靈活的商業性契約，以維持成長並保障利潤率。首先，他們應優先進行可靠的真實世界證據（RWE）舉措和上市後註冊研究，以記錄器械在關鍵適應症（例如吻合口、消化道和放射相關良性狹窄，以及惡性阻塞和瘻管的治療）中的表現。這些數據資產將有助於加強與支付方的談判，並促進在以治療結果衡量作為保險覆蓋要求的環境中推廣應用。其次，他們應審查籌資策略，以減少對單一國家的依賴，並制定緊急時應對計畫，包括合格的替代供應商、區域庫存中心以及允許在不影響臨床性能的前提下替換對關稅敏感的組件的設計方案。

我們採用透明的多來源調查方法，結合對臨床醫生的訪談、對監管和臨床文獻的審查以及使用三角測量法的供應鏈分析，得出檢驗的戰略見解。

本研究整合了一種結構化的調查方法，結合了來自一手定性研究的洞見、系統的二手分析以及嚴謹的檢驗，從而得出可靠的結論和建議。此方法首先進行針對性的一手研究，包括對介入性胃腸病學家、醫院採購經理、臨床試驗主要研究者和高級法規事務專業人員進行深入訪談。這提供了關於器械性能、臨床工作流程和採購要求的第一手觀點。此外，也透過對同儕審查的臨床文獻、監管申報文件、器械標籤和會議論文集進行系統性回顧，來闡明器械類型、材料特性和發展趨勢，從而補充上述一手資訊。

整合臨床、營運和商業性需求，領導者必須整合這些需求，以確保在不斷發展的食道支架市場中保持永續的競爭優勢

總之，食道支架領域正處於一個轉折點，材料創新、低急性護理機構的興起以及對臨床療效日益成長的期望交織在一起，正在重塑臨床實踐和商業策略。能夠針對特定臨床適應症設計產品的製造商——無論是用於治療某些良性狹窄的臨時性可生物分解支架，還是用於治療惡性梗阻和瘻管的堅固金屬結構——都將更有能力滿足臨床醫生的需求，並經受住支付方的嚴格審查。同時，供應鏈的韌性和靈活的商業模式對於在應對不斷變化的貿易政策和採購壓力的同時，維持醫療服務的可及性至關重要。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 食道支架市場：依產品類型分類

  • 可生物分解
  • 塑膠
    • 聚乙烯
    • 聚氨酯
  • 自膨脹金屬塗層
    • 鎳鈦諾
    • 不銹鋼
  • 自膨脹金屬（未塗層）
    • 鎳鈦諾
    • 不銹鋼

第9章 食道支架市場：依應用領域分類

  • 良性狹窄
    • 吻合口狹窄
    • 消化性狹窄
    • 放射學狹窄
  • 瘻管/穿孔
  • 惡性狹窄

第10章 食道支架市場：依最終用戶分類

  • 門診手術中心
  • 醫院
    • 私立醫院
    • 公立醫院
  • 專科診所

第11章 食道支架市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第12章 食道支架市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第13章 食道支架市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第14章：美國食道支架市場

第15章：中國食道支架市場

第16章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Advin Healthcare Private Limited
  • Boston Scientific Corporation
  • Changzhou Health Microport Medical Device Co., LTD.
  • Cook Group Incorporated
  • ELLA-CS, sro
  • ENDO-FLEX GmbH. by Medi-Globe Group
  • Leufen Medical by bess AG.
  • MITECH.
  • Medorah Meditek Pvt. Ltd.
  • Medtronic plc
  • Merit Medical Systems, Inc.
  • MICRO-TECH（Nanjing）Co., Ltd.
  • Micro-Tech Endoscopy
  • Mitra Industries Pvt. Ltd.
  • Olympus Corporation
  • S&G Biotech Inc.
  • TAEWOONG MEDICAL Co., Ltd
  • WL Gore & Associates, Inc.
Product Code: MRR-5D693B46C01D

The Esophageal Stents Market was valued at USD 169.92 million in 2025 and is projected to grow to USD 179.69 million in 2026, with a CAGR of 6.46%, reaching USD 263.42 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 169.92 million
Estimated Year [2026] USD 179.69 million
Forecast Year [2032] USD 263.42 million
CAGR (%) 6.46%

Framing the clinical importance and commercial context of esophageal stents amid innovations in device design, procedural settings, and stakeholder decision drivers

Esophageal stents have become a cornerstone intervention within multidisciplinary care pathways for obstructive and perforative esophageal disease, bridging palliation, definitive management, and temporizing measures depending on clinical context. Recent innovations in materials science, delivery systems, and stent design have expanded clinician choice and refined procedural workflows, while evolving reimbursement models and outpatient procedural settings have shifted how care is delivered. As devices evolve, stakeholders from interventional gastroenterologists to hospital supply chain leaders face complex trade-offs between clinical performance, procedural efficiency, and long-term durability.

This introduction synthesizes current device typologies, common clinical indications, and the macroeconomic and regulatory dynamics that shape procurement and adoption. It sets the stage for a deeper examination of transformative shifts in device technology, the ramifications of emergent trade policies, segmentation-driven commercial implications, regional variation in uptake, competitive behaviors among manufacturers, and pragmatic recommendations for leaders. Throughout, the emphasis is on translating technical developments into operational and strategic insights that support optimal patient outcomes and sustainable commercial models.

How converging advances in materials, delivery systems, regulatory focus, and care-site migration are redefining clinical practice and commercial models for esophageal stents

The landscape for esophageal stents is undergoing transformative shifts driven by technological refinement, clinical practice changes, and supply chain modernization. Advances in material engineering have accelerated the adoption of self-expanding metallic devices with improved radial force control and conformability, and simultaneous progress in biodegradable polymers is creating alternative pathways for temporary scaffolding that reduce the need for device retrieval. Delivery system miniaturization and enhanced fluoroscopic visibility have shortened procedural time in many cases, enabling more procedures to migrate from inpatient operating rooms to ambulatory surgical centers and specialty clinics. Consequently, clinicians can offer less invasive options with faster recovery, which reshapes referral patterns and payer conversations.

Alongside device innovation, regulatory emphasis on post-market surveillance and real-world evidence has heightened manufacturers' focus on longitudinal clinical outcomes and device registries. Health systems increasingly require demonstrable value through measurable reductions in complication rates and reintervention, prompting manufacturers to invest in data infrastructure and clinical partnerships. On the commercial front, consolidation among providers and payers is concentrating purchasing power, encouraging manufacturers to develop bundled-service propositions and flexible contracting models. Meanwhile, digital health tools that support pre-procedural planning, intra-procedural guidance, and remote follow-up are emerging as differentiators that align clinical utility with operational efficiencies, further accelerating the shift toward integrated care delivery models.

Assessment of the comprehensive operational, clinical access, and procurement consequences arising from United States tariff measures on imported medical device components and finished devices

The introduction of new tariff measures in the United States in 2025 has prompted a series of operational and strategic responses across the esophageal stent value chain, with effects felt from raw-material procurement to hospital purchasing committees. Tariff-related cost pressures have encouraged device manufacturers to reassess sourcing footprints and to explore alternative materials or domestic supply agreements to mitigate exposure. In some cases, companies have accelerated consolidation of component sourcing with preferred partners to preserve predictability in price and lead time, while others have pursued incremental redesigns that reduce reliance on tariff-sensitive inputs.

Clinicians and health system procurement teams have experienced downstream impacts through extended lead times and altered vendor negotiations, which in turn influence inventory management and procedural scheduling. To preserve access and keep procedures on schedule, hospitals have adopted a range of strategies including multi-vendor contracting, strategic inventory buffers, and closer collaboration with clinical teams to prioritize device allocation for high-acuity cases. Simultaneously, payers and hospital finance leaders are reassessing procedure cost structures and reimbursement assumptions, leading to renewed emphasis on demonstrable clinical benefit and total cost of care. These cumulative adjustments underscore the need for cross-functional coordination, with supply chain, clinical leadership, and commercial teams working together to maintain continuity of care while navigating elevated import-related costs and heightened regulatory scrutiny.

Segment-specific implications for product design, clinical selection criteria, and procurement approaches derived from detailed product, application, and end-user distinctions

Insight into segmentation reveals that device strategy and commercialization must be finely tailored to product design, clinical indication, and end-user environment to maximize clinical fit and commercial traction. Product type distinctions-ranging from biodegradable platforms to plastic constructs and self-expanding metallic options-carry unique clinical trade-offs. Biodegradable stents are positioned for temporary scaffolding scenarios where avoidance of removal confers clinical advantages, whereas plastic stents such as those constructed from polyethylene or polyurethane continue to serve defined niches where cost, ease of deployment, or specific mechanical properties are prioritized. Self-expanding metallic covered devices, available in nitinol and stainless steel variants, tend to offer differences in conformity and radial force that influence selection for sealing fistulae or palliation of malignant strictures, while self-expanding metallic uncovered versions, also in nitinol and stainless steel, remain relevant when tissue ingrowth and long-term patency considerations dominate clinical decision making.

Application-focused segmentation further clarifies clinical pathways and commercial messaging. Benign strictures-subdivided into anastomotic, peptic, and radiation-related etiologies-require particular attention to long-term remodeling and the risk-benefit profile of temporary versus permanent scaffolds. Fistula and perforation cases demand rapid sealing and high immediate radial support to prevent contamination and facilitate healing, while malignant strictures prioritize palliation, luminal patency, and quality-of-life outcomes. End-user segmentation highlights differences in procedural setting and procurement complexity: ambulatory surgical centers may prioritize devices optimized for efficiency and rapid turnover, hospitals-both private and public-must balance broad therapeutic portfolios and budget cycles, and specialty clinics often focus on niche procedural volumes and clinician preference patterns. Taken together, these intersecting segmentation lenses indicate that successful product strategies are those that align material science and design with specific clinical indications and the operational realities of the deploying institution.

How regional regulatory frameworks, payer structures, and supply chain realities across the Americas, Europe Middle East & Africa, and Asia-Pacific shape adoption and commercialization strategies

Regional dynamics exert a strong influence on regulatory frameworks, reimbursement practices, and clinical adoption patterns for esophageal stents, requiring manufacturers and service providers to adopt regionally differentiated strategies. In the Americas, the clinical emphasis on minimally invasive interventions and mature reimbursement systems has supported the adoption of advanced self-expanding metallic devices and the integration of device-related outcomes data into value-based contracting discussions. Conversely, supply chain disruptions and tariff-related complexities in the region have prompted closer collaboration between manufacturers and large hospital systems to ensure continuity of supply and to align contracting terms with procedural volumes.

Across Europe, the Middle East & Africa, regulatory heterogeneity and variable healthcare funding models shape adoption in distinct ways. In parts of Europe, strong registries and health technology assessment processes raise the bar for clinical evidence and post-market follow-up, favoring manufacturers that can demonstrate longitudinal outcomes and cost-effectiveness. In several Middle Eastern and African markets, infrastructural constraints and centralized procurement mechanisms influence device mix and pricing dynamics, often creating opportunities for durable, lower-cost solutions and for partnerships that include clinician training and support. In the Asia-Pacific region, rapid hospital capacity expansion, increasing procedural volumes, and investments in domestic manufacturing capacity are accelerating uptake of both metallic and biodegradable platforms, with local regulatory pathways and partnerships frequently shaping the speed and nature of market entry. Across all regions, evolving patient demographics and rising incidence of esophageal disease underscore persistent demand, but successful market strategies require nuanced alignment with regional clinical practice patterns, regulatory expectations, and procurement ecosystems.

Competitive differentiation through materials innovation, data-enabled clinical support, and strategic commercial partnerships that influence contract wins and clinician adoption

Company-level dynamics are being reshaped by a combination of product innovation, strategic partnerships, and operational responsiveness to supply chain and regulatory demands. Leading manufacturers are differentiating through investments in material science, optimizing nitinol and stainless steel alloy processes to achieve refined radial force profiles, and advancing biodegradable polymer formulations for temporary stenting applications. In addition, several firms are expanding their value propositions beyond pure device supply by offering training programs, digital procedural planning tools, and registry-based outcome tracking that enhance clinical adoption and support payer conversations on value.

Competitive positioning also reflects different go-to-market models: some companies emphasize direct relationships with large hospital systems and integrated health networks, while others leverage distributor channels and partnerships with local firms to navigate complex regulatory and procurement landscapes. Strategic collaborations between device manufacturers and diagnostic or imaging technology providers are becoming more common, enabling combined offerings that improve placement precision and reduce procedure time. At the same time, mid-sized firms and new entrants often compete on niche innovation, speed to market in specific regulatory jurisdictions, and agility in customizing products for distinct clinical segments. Manufacturing footprint decisions, supplier diversification, and commitment to quality systems and post-market surveillance remain decisive factors affecting credibility and long-term contract viability.

Practical and prioritized steps for manufacturers and health system leaders to strengthen evidence generation, diversify supply chains, and align commercial models with clinical site requirements

Industry leaders should adopt a multi-dimensional approach that integrates clinical evidence generation, supply chain resilience, and commercially flexible contracting to sustain growth and protect margins. First, prioritize robust real-world evidence initiatives and post-market registries that capture device performance across key indications such as anastomotic, peptic, and radiation-related benign strictures, as well as malignant obstruction and fistula management. These data assets will strengthen payer negotiations and facilitate adoption in settings where outcomes measurement is a prerequisite for formulary inclusion. Second, reassess sourcing strategies to reduce exposure to single-country supply chains, and develop contingency plans that include qualified alternative suppliers, localized inventory hubs, and design options that permit substitution of tariff-sensitive components without undermining clinical performance.

Third, tailor commercial models to end-user needs by offering device portfolios and service bundles suited to ambulatory surgical centers, private and public hospitals, and specialty clinics. This includes flexible pricing, training and proctoring packages, and outcome-based contracting where appropriate. Fourth, invest in clinician education and digital tools that enhance procedural efficiency and placement accuracy, thereby improving clinical outcomes and demonstrating value to payers. Finally, engage proactively with regulatory authorities and health technology assessment bodies to align evidence generation plans and to expedite market access in priority geographies. Taken together, these actions will enable manufacturers and health systems to navigate evolving trade environments, meet clinician expectations, and deliver sustainable patient-centered care.

A transparent multi-source methodology combining clinician interviews, regulatory and clinical literature review, and triangulated supply chain analysis to produce validated strategic insights

This research synthesizes a structured methodology that blends primary qualitative insights, systematic secondary analysis, and rigorous triangulation to ensure credible conclusions and actionable recommendations. The approach begins with targeted primary engagements including in-depth interviews with interventional gastroenterologists, hospital procurement leads, clinical trial investigators, and senior regulatory affairs professionals to capture frontline perspectives on device performance, clinical workflows, and procurement imperatives. These primary inputs are complemented by a systematic review of peer-reviewed clinical literature, regulatory filings, device labeling, and conference proceedings to map device typologies, material properties, and outcome trends.

Data synthesis employs triangulation across sources to reconcile differences and to surface consistent themes, with attention to geographic variability in regulatory requirements and procurement practices. Segmentation frameworks are validated against clinician- and institution-level feedback to ensure practical relevance, and supply chain analyses incorporate publicly available trade data and verified supplier disclosures. Limitations are acknowledged: clinical practice variation and evolving regulatory guidance can change the operational landscape, and proprietary contract terms between manufacturers and large customers are not always fully transparent. Throughout, ethical standards for research are observed, and claims are grounded in verified evidence and expert input to support defensible, actionable insights.

Synthesis of clinical, operational, and commercial imperatives that leaders must integrate to secure durable advantage in the evolving esophageal stent landscape

In conclusion, the esophageal stent sector is at an inflection point where material innovation, procedural migration to lower-acuity sites, and heightened expectations for real-world outcomes converge to reshape clinical practice and commercial strategy. Manufacturers that align product design with specific clinical indications-whether temporary biodegradable scaffolding for select benign strictures or robust metallic constructs for malignant obstruction and fistula-will be better positioned to satisfy clinician needs and payer scrutiny. Concurrently, supply chain resilience and adaptive commercial models are critical to navigate trade policy shifts and procurement pressures while preserving access to care.

Looking ahead, strategic emphasis on evidence generation, clinician support, and regional market tailoring will determine which organizations capture sustainable advantage. Stakeholders who prioritize interoperability between device performance data and health system value frameworks, while maintaining flexible manufacturing and sourcing strategies, will be best placed to respond to evolving clinical demands and regulatory expectations. Ultimately, the pathway to durable success in this sector requires integrated planning across R&D, regulatory affairs, supply chain, and commercial teams to deliver devices that demonstrably improve patient outcomes and operational efficiency.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Esophageal Stents Market, by Product Type

  • 8.1. Biodegradable
  • 8.2. Plastic
    • 8.2.1. Polyethylene
    • 8.2.2. Polyurethane
  • 8.3. Self Expanding Metallic Covered
    • 8.3.1. Nitinol
    • 8.3.2. Stainless Steel
  • 8.4. Self Expanding Metallic Uncovered
    • 8.4.1. Nitinol
    • 8.4.2. Stainless Steel

9. Esophageal Stents Market, by Application

  • 9.1. Benign Stricture
    • 9.1.1. Anastomotic Stricture
    • 9.1.2. Peptic Stricture
    • 9.1.3. Radiation Stricture
  • 9.2. Fistula Perforation
  • 9.3. Malignant Stricture

10. Esophageal Stents Market, by End User

  • 10.1. Ambulatory Surgical Center
  • 10.2. Hospital
    • 10.2.1. Private Hospital
    • 10.2.2. Public Hospital
  • 10.3. Specialty Clinic

11. Esophageal Stents Market, by Region

  • 11.1. Americas
    • 11.1.1. North America
    • 11.1.2. Latin America
  • 11.2. Europe, Middle East & Africa
    • 11.2.1. Europe
    • 11.2.2. Middle East
    • 11.2.3. Africa
  • 11.3. Asia-Pacific

12. Esophageal Stents Market, by Group

  • 12.1. ASEAN
  • 12.2. GCC
  • 12.3. European Union
  • 12.4. BRICS
  • 12.5. G7
  • 12.6. NATO

13. Esophageal Stents Market, by Country

  • 13.1. United States
  • 13.2. Canada
  • 13.3. Mexico
  • 13.4. Brazil
  • 13.5. United Kingdom
  • 13.6. Germany
  • 13.7. France
  • 13.8. Russia
  • 13.9. Italy
  • 13.10. Spain
  • 13.11. China
  • 13.12. India
  • 13.13. Japan
  • 13.14. Australia
  • 13.15. South Korea

14. United States Esophageal Stents Market

15. China Esophageal Stents Market

16. Competitive Landscape

  • 16.1. Market Concentration Analysis, 2025
    • 16.1.1. Concentration Ratio (CR)
    • 16.1.2. Herfindahl Hirschman Index (HHI)
  • 16.2. Recent Developments & Impact Analysis, 2025
  • 16.3. Product Portfolio Analysis, 2025
  • 16.4. Benchmarking Analysis, 2025
  • 16.5. Advin Healthcare Private Limited
  • 16.6. Boston Scientific Corporation
  • 16.7. Changzhou Health Microport Medical Device Co., LTD.
  • 16.8. Cook Group Incorporated
  • 16.9. ELLA-CS, s.r.o.
  • 16.10. ENDO-FLEX GmbH. by Medi-Globe Group
  • 16.11. Leufen Medical by bess AG.
  • 16.12. M.I.TECH.
  • 16.13. Medorah Meditek Pvt. Ltd.
  • 16.14. Medtronic plc
  • 16.15. Merit Medical Systems, Inc.
  • 16.16. MICRO-TECH (Nanjing) Co., Ltd.
  • 16.17. Micro-Tech Endoscopy
  • 16.18. Mitra Industries Pvt. Ltd.
  • 16.19. Olympus Corporation
  • 16.20. S&G Biotech Inc.
  • 16.21. TAEWOONG MEDICAL Co., Ltd
  • 16.22. W. L. Gore & Associates, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ESOPHAGEAL STENTS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL ESOPHAGEAL STENTS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. UNITED STATES ESOPHAGEAL STENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 11. CHINA ESOPHAGEAL STENTS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY BIODEGRADABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY BIODEGRADABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY BIODEGRADABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY PLASTIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY PLASTIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY PLASTIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY POLYETHYLENE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY POLYETHYLENE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY POLYETHYLENE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY POLYURETHANE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY POLYURETHANE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY POLYURETHANE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC COVERED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC COVERED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC COVERED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC COVERED, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY NITINOL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY NITINOL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY NITINOL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY STAINLESS STEEL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY STAINLESS STEEL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY STAINLESS STEEL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC UNCOVERED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC UNCOVERED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC UNCOVERED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC UNCOVERED, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY NITINOL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY NITINOL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY NITINOL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY STAINLESS STEEL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY STAINLESS STEEL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY STAINLESS STEEL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY BENIGN STRICTURE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY BENIGN STRICTURE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY BENIGN STRICTURE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY BENIGN STRICTURE, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY ANASTOMOTIC STRICTURE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY ANASTOMOTIC STRICTURE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY ANASTOMOTIC STRICTURE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY PEPTIC STRICTURE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY PEPTIC STRICTURE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY PEPTIC STRICTURE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY RADIATION STRICTURE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY RADIATION STRICTURE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY RADIATION STRICTURE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY FISTULA PERFORATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY FISTULA PERFORATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY FISTULA PERFORATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY MALIGNANT STRICTURE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY MALIGNANT STRICTURE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY MALIGNANT STRICTURE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY HOSPITAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY HOSPITAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY PRIVATE HOSPITAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY PRIVATE HOSPITAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY PRIVATE HOSPITAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY PUBLIC HOSPITAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY PUBLIC HOSPITAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY PUBLIC HOSPITAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY SPECIALTY CLINIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY SPECIALTY CLINIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY SPECIALTY CLINIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. AMERICAS ESOPHAGEAL STENTS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 75. AMERICAS ESOPHAGEAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 76. AMERICAS ESOPHAGEAL STENTS MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 77. AMERICAS ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC COVERED, 2018-2032 (USD MILLION)
  • TABLE 78. AMERICAS ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC UNCOVERED, 2018-2032 (USD MILLION)
  • TABLE 79. AMERICAS ESOPHAGEAL STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 80. AMERICAS ESOPHAGEAL STENTS MARKET SIZE, BY BENIGN STRICTURE, 2018-2032 (USD MILLION)
  • TABLE 81. AMERICAS ESOPHAGEAL STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 82. AMERICAS ESOPHAGEAL STENTS MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 83. NORTH AMERICA ESOPHAGEAL STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. NORTH AMERICA ESOPHAGEAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 85. NORTH AMERICA ESOPHAGEAL STENTS MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 86. NORTH AMERICA ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC COVERED, 2018-2032 (USD MILLION)
  • TABLE 87. NORTH AMERICA ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC UNCOVERED, 2018-2032 (USD MILLION)
  • TABLE 88. NORTH AMERICA ESOPHAGEAL STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 89. NORTH AMERICA ESOPHAGEAL STENTS MARKET SIZE, BY BENIGN STRICTURE, 2018-2032 (USD MILLION)
  • TABLE 90. NORTH AMERICA ESOPHAGEAL STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 91. NORTH AMERICA ESOPHAGEAL STENTS MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 92. LATIN AMERICA ESOPHAGEAL STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. LATIN AMERICA ESOPHAGEAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 94. LATIN AMERICA ESOPHAGEAL STENTS MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 95. LATIN AMERICA ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC COVERED, 2018-2032 (USD MILLION)
  • TABLE 96. LATIN AMERICA ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC UNCOVERED, 2018-2032 (USD MILLION)
  • TABLE 97. LATIN AMERICA ESOPHAGEAL STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 98. LATIN AMERICA ESOPHAGEAL STENTS MARKET SIZE, BY BENIGN STRICTURE, 2018-2032 (USD MILLION)
  • TABLE 99. LATIN AMERICA ESOPHAGEAL STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 100. LATIN AMERICA ESOPHAGEAL STENTS MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA ESOPHAGEAL STENTS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA ESOPHAGEAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA ESOPHAGEAL STENTS MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC COVERED, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC UNCOVERED, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA ESOPHAGEAL STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA ESOPHAGEAL STENTS MARKET SIZE, BY BENIGN STRICTURE, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA ESOPHAGEAL STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE, MIDDLE EAST & AFRICA ESOPHAGEAL STENTS MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPE ESOPHAGEAL STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPE ESOPHAGEAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE ESOPHAGEAL STENTS MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPE ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC COVERED, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPE ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC UNCOVERED, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPE ESOPHAGEAL STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPE ESOPHAGEAL STENTS MARKET SIZE, BY BENIGN STRICTURE, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPE ESOPHAGEAL STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPE ESOPHAGEAL STENTS MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 119. MIDDLE EAST ESOPHAGEAL STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. MIDDLE EAST ESOPHAGEAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 121. MIDDLE EAST ESOPHAGEAL STENTS MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 122. MIDDLE EAST ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC COVERED, 2018-2032 (USD MILLION)
  • TABLE 123. MIDDLE EAST ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC UNCOVERED, 2018-2032 (USD MILLION)
  • TABLE 124. MIDDLE EAST ESOPHAGEAL STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 125. MIDDLE EAST ESOPHAGEAL STENTS MARKET SIZE, BY BENIGN STRICTURE, 2018-2032 (USD MILLION)
  • TABLE 126. MIDDLE EAST ESOPHAGEAL STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 127. MIDDLE EAST ESOPHAGEAL STENTS MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 128. AFRICA ESOPHAGEAL STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 129. AFRICA ESOPHAGEAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 130. AFRICA ESOPHAGEAL STENTS MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 131. AFRICA ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC COVERED, 2018-2032 (USD MILLION)
  • TABLE 132. AFRICA ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC UNCOVERED, 2018-2032 (USD MILLION)
  • TABLE 133. AFRICA ESOPHAGEAL STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 134. AFRICA ESOPHAGEAL STENTS MARKET SIZE, BY BENIGN STRICTURE, 2018-2032 (USD MILLION)
  • TABLE 135. AFRICA ESOPHAGEAL STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 136. AFRICA ESOPHAGEAL STENTS MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 137. ASIA-PACIFIC ESOPHAGEAL STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 138. ASIA-PACIFIC ESOPHAGEAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 139. ASIA-PACIFIC ESOPHAGEAL STENTS MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 140. ASIA-PACIFIC ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC COVERED, 2018-2032 (USD MILLION)
  • TABLE 141. ASIA-PACIFIC ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC UNCOVERED, 2018-2032 (USD MILLION)
  • TABLE 142. ASIA-PACIFIC ESOPHAGEAL STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 143. ASIA-PACIFIC ESOPHAGEAL STENTS MARKET SIZE, BY BENIGN STRICTURE, 2018-2032 (USD MILLION)
  • TABLE 144. ASIA-PACIFIC ESOPHAGEAL STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 145. ASIA-PACIFIC ESOPHAGEAL STENTS MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 146. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 147. ASEAN ESOPHAGEAL STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 148. ASEAN ESOPHAGEAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 149. ASEAN ESOPHAGEAL STENTS MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 150. ASEAN ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC COVERED, 2018-2032 (USD MILLION)
  • TABLE 151. ASEAN ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC UNCOVERED, 2018-2032 (USD MILLION)
  • TABLE 152. ASEAN ESOPHAGEAL STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 153. ASEAN ESOPHAGEAL STENTS MARKET SIZE, BY BENIGN STRICTURE, 2018-2032 (USD MILLION)
  • TABLE 154. ASEAN ESOPHAGEAL STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 155. ASEAN ESOPHAGEAL STENTS MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 156. GCC ESOPHAGEAL STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 157. GCC ESOPHAGEAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 158. GCC ESOPHAGEAL STENTS MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 159. GCC ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC COVERED, 2018-2032 (USD MILLION)
  • TABLE 160. GCC ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC UNCOVERED, 2018-2032 (USD MILLION)
  • TABLE 161. GCC ESOPHAGEAL STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 162. GCC ESOPHAGEAL STENTS MARKET SIZE, BY BENIGN STRICTURE, 2018-2032 (USD MILLION)
  • TABLE 163. GCC ESOPHAGEAL STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 164. GCC ESOPHAGEAL STENTS MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 165. EUROPEAN UNION ESOPHAGEAL STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 166. EUROPEAN UNION ESOPHAGEAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 167. EUROPEAN UNION ESOPHAGEAL STENTS MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 168. EUROPEAN UNION ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC COVERED, 2018-2032 (USD MILLION)
  • TABLE 169. EUROPEAN UNION ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC UNCOVERED, 2018-2032 (USD MILLION)
  • TABLE 170. EUROPEAN UNION ESOPHAGEAL STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 171. EUROPEAN UNION ESOPHAGEAL STENTS MARKET SIZE, BY BENIGN STRICTURE, 2018-2032 (USD MILLION)
  • TABLE 172. EUROPEAN UNION ESOPHAGEAL STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 173. EUROPEAN UNION ESOPHAGEAL STENTS MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 174. BRICS ESOPHAGEAL STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 175. BRICS ESOPHAGEAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 176. BRICS ESOPHAGEAL STENTS MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 177. BRICS ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC COVERED, 2018-2032 (USD MILLION)
  • TABLE 178. BRICS ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC UNCOVERED, 2018-2032 (USD MILLION)
  • TABLE 179. BRICS ESOPHAGEAL STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 180. BRICS ESOPHAGEAL STENTS MARKET SIZE, BY BENIGN STRICTURE, 2018-2032 (USD MILLION)
  • TABLE 181. BRICS ESOPHAGEAL STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 182. BRICS ESOPHAGEAL STENTS MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 183. G7 ESOPHAGEAL STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 184. G7 ESOPHAGEAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 185. G7 ESOPHAGEAL STENTS MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 186. G7 ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC COVERED, 2018-2032 (USD MILLION)
  • TABLE 187. G7 ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC UNCOVERED, 2018-2032 (USD MILLION)
  • TABLE 188. G7 ESOPHAGEAL STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 189. G7 ESOPHAGEAL STENTS MARKET SIZE, BY BENIGN STRICTURE, 2018-2032 (USD MILLION)
  • TABLE 190. G7 ESOPHAGEAL STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 191. G7 ESOPHAGEAL STENTS MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 192. NATO ESOPHAGEAL STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 193. NATO ESOPHAGEAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 194. NATO ESOPHAGEAL STENTS MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 195. NATO ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC COVERED, 2018-2032 (USD MILLION)
  • TABLE 196. NATO ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC UNCOVERED, 2018-2032 (USD MILLION)
  • TABLE 197. NATO ESOPHAGEAL STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 198. NATO ESOPHAGEAL STENTS MARKET SIZE, BY BENIGN STRICTURE, 2018-2032 (USD MILLION)
  • TABLE 199. NATO ESOPHAGEAL STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 200. NATO ESOPHAGEAL STENTS MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 201. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 202. UNITED STATES ESOPHAGEAL STENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 203. UNITED STATES ESOPHAGEAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 204. UNITED STATES ESOPHAGEAL STENTS MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 205. UNITED STATES ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC COVERED, 2018-2032 (USD MILLION)
  • TABLE 206. UNITED STATES ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC UNCOVERED, 2018-2032 (USD MILLION)
  • TABLE 207. UNITED STATES ESOPHAGEAL STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 208. UNITED STATES ESOPHAGEAL STENTS MARKET SIZE, BY BENIGN STRICTURE, 2018-2032 (USD MILLION)
  • TABLE 209. UNITED STATES ESOPHAGEAL STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 210. UNITED STATES ESOPHAGEAL STENTS MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 211. CHINA ESOPHAGEAL STENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 212. CHINA ESOPHAGEAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 213. CHINA ESOPHAGEAL STENTS MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 214. CHINA ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC COVERED, 2018-2032 (USD MILLION)
  • TABLE 215. CHINA ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC UNCOVERED, 2018-2032 (USD MILLION)
  • TABLE 216. CHINA ESOPHAGEAL STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 217. CHINA ESOPHAGEAL STENTS MARKET SIZE, BY BENIGN STRICTURE, 2018-2032 (USD MILLION)
  • TABLE 218. CHINA ESOPHAGEAL STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 219. CHINA ESOPHAGEAL STENTS MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)